Malaria is a mosquito-borne, hemolytic, febrile illness that infects over 250 million people and kills more than 1 million people per year.

It is caused by a parasite that is transmitted from one human to another by the bite of infected Anopheles mosquitoes. P. falciparum causes more severe disease than the other plasmodial species and accounts for most malaria deaths.

P. falciparum and P. vivax are the most common pathogens, however, there is considerable geographic variation in species distribution.

Intended Use
The Rapid Malaria p.f/p.v Test is a qualitative immunochromatographic to Plasmodium falciparum and Plasmodium vivax in serum, plasma or whole blood specimens. The test is intended for use by professionals only.

Hepatitis C is an infectious disease affecting primarily the liver, caused by the hepatitis C virus (HCV). The infection is often asymptomatic, but chronic infection can lead to scarring of the liver and ultimately to cirrhosis, which is generally apparent after many years.

In some cases, those with cirrhosis will go on to develop liver failure, liver cancer or life-threatening esophaeal and gastric varices.

Intended Use
The Rapid HCV Test is a single-use immunochromatographic assay for qualitative detection of antibodies to hepatitis C virus (HCV) in Whole Blood, Serum or Plasma.

It is intended for use by professional as an aid in the diagnosis of infections by Hepatitis C virus and screening for the potential carrier of this virus.

Hepatitis B is a viral infection of the liver caused by the hepatitis B virus (HBV). When a person is first infected with the hepatitis B virus, this is called an acute infection.

Symptoms include jaundice, fatigue, abdominal pain, loss of appetite, nausea, vomiting, and joint pain. HBV is transmitted by direct contact with body fluids.

This may occur either by skin punctures or otherwise broken skin or by contact with mucosal membranes. Some avenues of infection include contaminated needles or medical instruments, transfusion with contaminated blood or blood products, unprotected sex, and from neonatal/congenital.

Intended Use
The One Step Hepatitis B Surface Antigen Test is a colloidal gold/antibody complex based immunoassay designed for the qualitative determination of Hepatitis B Surface Antigen in serum or whole blood specimens.

It is intended for professional use as an aid in the diagnosis of infections by Hepatitis B virus and screening for the potential carrier of this virus.

The kit is intended for the qualitative detection of IgM antibodies to nine major pathogens of respiratory tract infections in human serum or plasma.

Detectable pathogens include: Mycoplasma Pneumonia, Chlamydia Pneumonia, Influenza A, Influenza B, Parainfluenza Virus Type 1, 2 and 3, Respiratory Syncytial Virus, Adenovirus, Coxsackievirus Group B and Legionella Pneumophila Serum Type 1.

QuikRead go wrCRP is a rapid test for the quantitative determination of C-reactive protein (CRP) values in whole blood, serum, and plasma with QuikRead go instrument.

QuikRead go wrCRP gives reliable wide range CRP results within minutes.

Wide range CRP testing with QuikRead go wrCRP
C-reactive protein (CRP) is a widely used analyte to help assess the severity of bacterial infection, guide diagnostic and treatment decisions, and monitor response to antibiotic treatment in various healthcare settings 1,2. QuikRead go wrCRP test helps to identify patients who benefit from antibiotics, it helps in monitoring the treatment outcome, and can be used to test for low level inflammation.

CRP point of care testing drives sustainable use of antibiotics and antimicrobial stewardship in healthcare.

The biomarker for venous thromboembolism

D-dimer is a small biomarker of coagulation activation and is present in the blood as a blood clot is degraded.

Response Biomedical offers a whole blood quantitative immunoassay D-dimer test, with our proprietary RAMP technology which assess the levels of D-dimer in patients around the world in ~15 minutes.

Read more about how this product will help with the challenges labs and physicians face, finding the right D-dimer test for your needs.

• Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) are diagnostically challenging conditions that carry a high cost if not recognized and treated promptly.
• Accurate diagnosis of DVT and PE remain a problem and with improper testing, risky, expensive, imaging and treatments may be done unnecessarily.
• DVT and PE present like many other medical problems, but emergency medicine doctors have no time to waste, and the majority of PE-related deaths occur within the first hour

The gold standard biomarker for heart failure (HF)

Response Biomedical offers a FDA cleared whole blood immunoassay NT-proBNP test, with our proprietary RAMP technology which detects the levels of N-terminal prohormone of brain natriuretic peptide in patients with congestive heart failure around the world.

Read more about how this product will help your physicians and patients where a traditional BNP test cannot.

• Provides rapid, accurate diagnoses and assessment of congestive heart failure.
• NT-proBNP is roughly 5 times more stable of a biomarker then BNP
• Better accuracy in mild heart failure patients because the levels of NT-proBNP are 2-10x higher
• Standardized to Roche Elecsys Lab Analyzer

The definitive biomarker for acute myocardial infarction (AMI)

• Cardiac Troponin is the gold standard test for myocardial infarction and is usually the first test ordered for patients with chest pain

• Measurements of cardiac troponin I can improve diagnosis and treatment of myocardial infarction (MI)

• With RAMP Troponin I, healthcare professionals can obtain a quantitative measurement of cardiac troponin I from 75uL of blood without the need for centrifugation

• RAMP tests are individual, single-use quantitative tests that provide rapid, accurate, lab quality results within minutes